• Explore /
  • Poster
  • / A phase I/II study of nivolumab and axitinib in patients with advanced renal cell carcinoma.

A phase I/II study of nivolumab and axitinib in patients with advanced renal cell carcinoma.

Abstract Poster

Authors

null

Matthew R. Zibelman

Fox Chase Cancer Center, Philadelphia, PA

Matthew R. Zibelman , Michael Anthony Carducci , Yasser Ged , Ana M. Molina , Rahul Ravilla , David R. Shaffer , Courtney Lambert , Mahvish Tafseer , Rachel Basiura , Danielle Weismann , Rutika Kokate , Karthik Devarajan , Karen Ruth , Fern Anari , Pooja Ghatalia , Daniel M. Geynisman , Elizabeth R. Plimack , R. Katherine Alpaugh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03172754

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 291)

DOI

10.1200/JCO.2022.40.6_suppl.291

Abstract #

291

Poster Bd #

D2

Abstract Disclosures

Similar Posters

First Author: Giuseppe Procopio

First Author: Matthew R. Zibelman

Poster

2017 Genitourinary Cancers Symposium

Correlation of insulin-receptor expression with efficacy of axitinib in patients with advanced renal cell carcinoma.

Correlation of insulin-receptor expression with efficacy of axitinib in patients with advanced renal cell carcinoma.

First Author: Masayuki Takahashi

First Author: Joseph Vento